2024-04-23  11:04:35 AM Chg. +2.00 Volume Bid11:04:35 AM Ask11:04:35 AM Market Capitalization Dividend Y. P/E Ratio
230.00CHF +0.88% 299
Turnover: 68,713
228.50Bid Size: 33 230.00Ask Size: 15 3.45 bill.CHF - 35.98

Business description

Dottikon ES Holding AG manufactures high-quality performance chemicals, intermediates and exclusive active pharmaceutical ingredients (APIs) for the world's leading chemical and pharmaceutical industry. The company with its production site in Dottikon (Aargau, Switzerland) is specialized in hazardous reactions and is positioning itself as strategic development and manufacturing partner. Its safety culture created over the last 100 years guides innovative uses of hazardous reactions, low-temperature and high-pressure chemistry, as well as continuous processing. This shortens conventional chemical synthesis routes, increases yields, selectivities and purities, and reduces waste. The versatile technology and equipment portfolio is used to design, develop and optimize chemical processes, and scale up from kilograms to multi-tons. The technology portfolio is built around active pharmaceutical ingredients (APIs) and performance chemicals and comprises hazardous reactions, low-temperature and high-pressure reactions as well as continuous processing.
 

Management board & Supervisory board

CEO
Dr. Markus Blocher
Management board
Marlene Born, Karin Krause, Dr. Stephan Kirschbaum, Dr. Urs Brändli, Dr. Thomas Rosatzin, Dr. Robert Dahinden, Dr. Rolf Schaller
Supervisory board
Dr. Markus Blocher, Dr. Alfred Scheidegger, Dr. Bernhard Urwyler
 

Company data

Name: Dottikon ES Holding AG
Address: Hembrunnstrasse 17,CH-5605 Dottikon
Phone: +41-56-616-8111
Fax: -
E-mail: info@dottikon.com
Internet: www.dottikon.com
Industry: Commodities
Sector: Chemicals
Sub sector: -
End of financial year: 03-31
Free Float: 16.20%
IPO date: -

Investor relations

Name: Marlene Born
IR phone: +41-56-616-8201
IR Fax: -
IR e-mail: investor-relations@d...kon.com investor-relations@dottikon.com

Company calendar

CW 22 | 2024-05-28 4th Quarter/Annual Report
CW 27 | 2024-07-05 General Shareholder Meeting
CW 48 | 2024-11-29 Interim Report 2nd Quarter/6 Months
 

Main Shareholders

Markus Blocher
 
67.60%
Others
 
17.00%
Peter Grogg
 
7.00%
Miriam Baumann
 
5.10%
UBS Fund Management
 
3.30%